Compare PRCH & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRCH | BLFS |
|---|---|---|
| Founded | 2012 | 1987 |
| Country | United States | United States |
| Employees | N/A | 155 |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.8B |
| IPO Year | 2019 | 2013 |
| Metric | PRCH | BLFS |
|---|---|---|
| Price | $17.05 | $39.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | $18.63 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 1.3M | 817.4K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.91 | 77.27 |
| EPS | 0.01 | ★ 0.94 |
| Revenue | ★ $482,414,000.00 | $96,214,000.00 |
| Revenue This Year | $4.15 | $19.73 |
| Revenue Next Year | $17.05 | $17.82 |
| P/E Ratio | $1,658.50 | ★ $40.98 |
| Revenue Growth | 10.18 | ★ 16.97 |
| 52 Week Low | $6.36 | $17.86 |
| 52 Week High | $18.37 | $38.91 |
| Indicator | PRCH | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 55.59 | 71.59 |
| Support Level | $15.49 | $34.38 |
| Resistance Level | $17.03 | N/A |
| Average True Range (ATR) | 0.82 | 0.92 |
| MACD | -0.04 | 0.23 |
| Stochastic Oscillator | 74.13 | 98.47 |
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has four reportable segments: Insurance Services, Software & Data, Consumer Services, and Corporate. The majority of revenue is from the Insurance segment. The Insurance Services segment manages and operates the Reciprocal, providing services related, but not limited, to underwriting, policy renewal, risk management, insurance portfolio management, financial management, and setting investment guidelines in exchange for commissions and fees.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.